Clinical relevance of bcl-2(MBR)J(H) rearrangement detected by polymerase chain reaction in the peripheral blood of patients with follicular lymphoma

British Journal of Cancer

Volumn 76, Issue 1, 1997, Pages 36-39

  Bertoni, F ^a   Bosshard, G ^a   Roggero, E ^a   Ceresa, E ^a   Cavalli, F ^a   Zucca, E ^a  

^a OSPEDALE SAN GIOVANNI   (Switzerland)

Author keywords

Bcl 2; Follicular lymphoma; Polymerase chain reaction; Prognostic factors; t(14; 18)

Indexed keywords

PROTEIN BCL 2;

ARTICLE; CANCER GENETICS; CANCER SURVIVAL; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; DIAGNOSTIC VALUE; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030982722     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.332     Document Type: Article

References (33)

1. Bell DA, Liu Y and Cortopassi GA (1995) Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J Natl Cancer Inst 87: 223-224
2. Berinstein NL, Reis MD, Ngan BY, Sawka CA, Jamal HH and Kuzniar B (1993) Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma. J Clin Oncol 11: 1344-1352
3. Betticher DC, Zucca E, Von Rohr A, Egger T, Radford JA, Ambrosetti A, Bürki K, Rufener B, Hsu Schmitz SF and Cemy T (1996) 2-Chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma. Ann Oncol 7: 793-799
4. Cabanillas F, Grillo-Lopez AJ, McLaughlin P, Link BK, Levy R, Czuczman M, Heyman MR, Williams M, Jain V, Bence-Bruckler I, Ho AD, Lister J, Rogers J, Shen D and Varns C (1996) Anti-CD20 antibody (MAB). IDEC-C2B8: clearance of bcl-2 t(14;18) positive cells from peripheral blood (PB) and bone marrow (BM) in patients (pts) with relapsed low-grade or follicular lymphoma (LG/F NHL). Blood 88 (suppl. 1): 91a
5. Corhally N, Grogan L, Dervan PA and Carney DN (1992) The detection of specific gene rearrangements in non-Hodgkin's lymphoma using the polymerase chain reaction. Br J Cancer 66: 805-809
6. Cotter F, Price C, Zucca E and Young BD (1990) Direct sequence analysis of the 14q+ and 18q- chromosome junctions in follicular lymphoma. Blood 76: 131-135
7. μ+ and 18μ chromosome junctions at MBR and MCR revealing clustering within the MBR in follicular lymphoma. Ann Oncol 2 (suppl.2): 93-97
8. Croce CM (1993) Molecular biology of lymphomas. Semin Oncol 20: 31-46
9. H rearrangements in circulating B cells of healthy blood donors and patients with non malignant diseases. J Clin Oncol 14: 1333-1344
10. Finke J, Slanina J, Lange W and Dolken G (1993) Persistence of circulating t(14;18)-positive cells in long term remission after radiation therapy for localized-stage follicular lymphoma. J Clin Oncol 11: 1668-1673
11. Gribben JG, Freedman AS, Woo SD, Blake K, Shu RS, Freeman G, Longtine JA, Pinkus GS and Nadler LM (1991) All advanced non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78: 3275-3280
12. Gribben JG, Neuberg D, Barber M, Moore J, Pesek KW, Freedman AS and Nadler LM (1994) Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83: 3800-3807
13. Hardingham JE, Kotasek D, Sage RE, Gooley LT, Mi JX, Dobrovic A, Norman JE, Bolton AE and Dale BM (1995) Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin's lymphoma. J Clin Oncol 13: 1073-1079
14. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G. De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Pins MA, Ralfkiaer E and Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361-1392
15. Hickish TF, Purvies H, Mansi J, Soukop M and Cunningham D (1991) Molecular monitoring of low grade non-Hodgkin's lymphoma by gene amplification. Hr J Cancer 64: 1161-1163
16. Hockenberry D, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336
17. Ji W, Qu G, Ye P, Zhang XY, Halabi S and Ehrlich M (1995) Frequent detection of bel-2/JH translocation in human blood and organ samples by a quantitative polymerase chain reaction assay. Cancer Res 55: 2876-2882
18. Johnson A, Brun A, Dictor M, Rambech E, Akerman M and Anderson H (1995) Incidence and prognostic significance of t(14;18) translocation in follicle center cell lymphoma of low and high grade. Ann Oncol 6: 789-794
19. Lambrechts AC, Hupkes PE, Dorssers LCJ and Van't Veer MB (1993) Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin's lymphoma. Blood 82: 2510-2516
20. Lambrechts AC, Hupkes PE, Dorssers LCJ and Van't Veer MB (1994) Clinical significance of t(14;18)-positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J Clin Oncol 12: 1541-1546
21. Limpens J, Stad R, Vos C, De Vlaam C, De Jong D, Van Ommen GJB, Schuuring E and Kluin PM (1995) Lymphoma-associated translocalion t(14;18) in blood B cells of normal individuals. Blood 85: 2528-2536
22. Liu Y, Hernandez AM, Shibata D and Cortopassi GA (1994) BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA 91: 8910-8914
23. Lopez-Guillermo A, Lee MS, Pugh W, McLaughlin P and Cabanillas F (1996) The molecular breakpoint site of bcl-2 gene has prognostic importance in indolent follicular lymphoma (FL). Blood 88 (suppl. 1): 293a
24. Mrozek K and Bloomfield D (1993) Cytogenetics of indolent lymphomas. Semin Oncol 20: 47-57
25. Pezzella F, Jones M, Ralfkiaer E, Ersboll J, Gatter KC and Mason DY (1992) Evaluation of bcl-2 expression and 14;18 translocation as prognostic markers in follicular lymphoma. Br J Cancer 65: 87-89
26. Price CGA, Meerabux J, Murtagh S, Cotter FE, Rohatiner AZS, Young BD and Lister TA (1991) The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol 9: 1527-1532
27. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329: 987-994
28. The Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) National Cancer Institute Sponsored Study of classifications of non-Hodgkin's lymphomas. Cancer 49: 2112-2135
29. Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, Monconduit M and Bastard C (1994) Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 84: 1043-1049
30. Weiss LM, Warnke RA, Sklar J and Cleary ML (1987) Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 317: 1185-1189
31. Whang-Peng J, Knutsen T, Jaffe ES, Raffeld M, Zhao WP, Duffey P, Condron K, Yano T and Longo DL (1995) Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlation with cytogenetic, histologic, immunophenotyping and molecular studies. Blood 85: 203-216
32. Yuan R, Dowling P, Zucca E, Diggelman H and Cavalli F (1993) Detection of bcl-2/JH rearrangement in follicular and diffuse lymphoma: concordant results of peripheral blood and bone marrow analysis at diagnosis. Br J Cancer 67: 922-925
33. Yunis JJ, Frizzera G, Oken MM, McKenna J, Thelogides A and Amesen M (1987) Multiple recurrent genomic defects in follicular lymphoma. N Engl J Med 316: 79-84